APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosensors for Point-of-Care Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biosensors for Point-of-Care Diagnostics Market Outlook and Growth Opportunities 2026

4 July 2026203 pages

Choose your research edition.

Industry ResearchBiosensors for Point-of-Care Diagnostics Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosensors for Point-of-Care Diagnostics Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Biosensors for Point-of-Care Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosensors for Point-of-Care Diagnostics Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosensors for Point-of-Care Diagnostics Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Biosensors for Point-of-Care Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosensors for Point-of-Care Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biosensors for Point-of-Care Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biosensors for Point-of-Care Diagnostics market include Abbott, Medtronic, Universal Biosensors, Sysmex Corporation, Siemens, Pharmaco-Kinesis Corporation (PKC), Nova Biomedical, LifeSensors and LifeScan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biosensors for Point-of-Care Diagnostics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biosensors for Point-of-Care Diagnostics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biosensors for Point-of-Care Diagnostics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biosensors for Point-of-Care Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

Biosensors for Point-of-Care Diagnostics Segment by Company

Abbott

Medtronic

Universal Biosensors

Sysmex Corporation

Siemens

Pharmaco-Kinesis Corporation (PKC)

Nova Biomedical

LifeSensors

LifeScan

F. Hoffman-La Roche

Ercon

Biosensors International

Bio-Rad Laboratories

Biacore

Bayer Healthcare

Acon Laboratories

Biosensors for Point-of-Care Diagnostics Segment by Type

Electrochemical Biosensors

Optical Biosensors

Accelerometer Biosensors

Thermal Biosensors

Piezoelectric Biosensors

Biosensors for Point-of-Care Diagnostics Segment by Application

Clinic

Hospital

Home Care

Others

Biosensors for Point-of-Care Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biosensors for Point-of-Care Diagnostics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biosensors for Point-of-Care Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biosensors for Point-of-Care Diagnostics significant trends, drivers, influence factors in global and regions.

6. To analyze Biosensors for Point-of-Care Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosensors for Point-of-Care Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosensors for Point-of-Care Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosensors for Point-of-Care Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biosensors for Point-of-Care Diagnostics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biosensors for Point-of-Care Diagnostics industry.

Chapter 3: Detailed analysis of Biosensors for Point-of-Care Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biosensors for Point-of-Care Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biosensors for Point-of-Care Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biosensors for Point-of-Care Diagnostics Industry Trends Table 2. Biosensors for Point-of-Care Diagnostics Industry Drivers Table 3. Biosensors for Point-of-Care Diagnostics Industry Opportunities and Challenges Table 4. Biosensors for Point-of-Care Diagnostics Industry Restraints Table 5. Global Biosensors for Point-of-Care Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biosensors for Point-of-Care Diagnostics Revenue Share by Company (2021-2026) Table 7. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Company (k units) & (2021-2026) Table 8. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Company (2021-2026) Table 9. Global Biosensors for Point-of-Care Diagnostics Average Price (USD/unit) of Company (2021-2026) Table 10. Global Biosensors for Point-of-Care Diagnostics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biosensors for Point-of-Care Diagnostics Key Company Manufacturing Base & Headquarters Table 12. Global Biosensors for Point-of-Care Diagnostics Company, Product Type & Application Table 13. Global Biosensors for Point-of-Care Diagnostics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biosensors for Point-of-Care Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Electrochemical Biosensors Table 18. Significant Companies of Optical Biosensors Table 19. Significant Companies of Accelerometer Biosensors Table 20. Significant Companies of Thermal Biosensors Table 21. Significant Companies of Piezoelectric Biosensors Table 22. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type (2021-2026) & (k units) Table 24. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type (2027-2032) & (k units) Table 25. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Type (2021-2026) Table 26. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Type (2027-2032) Table 27. Global Biosensors for Point-of-Care Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biosensors for Point-of-Care Diagnostics Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Biosensors for Point-of-Care Diagnostics Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Type (2021-2026) Table 31. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Clinic Table 33. Significant Companies of Hospital Table 34. Significant Companies of Home Care Table 35. Significant Companies of Others Table 36. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application (2021-2026) & (k units) Table 38. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application (2027-2032) & (k units) Table 39. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Application (2021-2026) Table 40. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Application (2027-2032) Table 41. Global Biosensors for Point-of-Care Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Biosensors for Point-of-Care Diagnostics Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Biosensors for Point-of-Care Diagnostics Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Application (2021-2026) Table 45. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Application (2027-2032) Table 46. Global Biosensors for Point-of-Care Diagnostics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Biosensors for Point-of-Care Diagnostics Sales by Region (2021-2026) & (k units) Table 48. Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Region (2021-2026) Table 49. Global Biosensors for Point-of-Care Diagnostics Sales by Region (2027-2032) & (k units) Table 50. Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Region (2027-2032) Table 51. Global Biosensors for Point-of-Care Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Biosensors for Point-of-Care Diagnostics Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Region (2021-2026) Table 54. Global Biosensors for Point-of-Care Diagnostics Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Region (2027-2032) Table 56. Global Biosensors for Point-of-Care Diagnostics Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global Biosensors for Point-of-Care Diagnostics Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global Biosensors for Point-of-Care Diagnostics Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Biosensors for Point-of-Care Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2026) & (k units) Table 61. Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Country (2021-2026) Table 62. Global Biosensors for Point-of-Care Diagnostics Sales by Country (2027-2032) & (k units) Table 63. Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Country (2027-2032) Table 64. Global Biosensors for Point-of-Care Diagnostics Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Biosensors for Point-of-Care Diagnostics Sales Value Market Share by Country (2021-2026) Table 66. Global Biosensors for Point-of-Care Diagnostics Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Biosensors for Point-of-Care Diagnostics Sales Value Market Share by Country (2027-2032) Table 68. Abbott Company Information Table 69. Abbott Business Overview Table 70. Abbott Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Abbott Biosensors for Point-of-Care Diagnostics Product Portfolio Table 72. Abbott Recent Development Table 73. Medtronic Company Information Table 74. Medtronic Business Overview Table 75. Medtronic Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Medtronic Biosensors for Point-of-Care Diagnostics Product Portfolio Table 77. Medtronic Recent Development Table 78. Universal Biosensors Company Information Table 79. Universal Biosensors Business Overview Table 80. Universal Biosensors Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Universal Biosensors Biosensors for Point-of-Care Diagnostics Product Portfolio Table 82. Universal Biosensors Recent Development Table 83. Sysmex Corporation Company Information Table 84. Sysmex Corporation Business Overview Table 85. Sysmex Corporation Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Sysmex Corporation Biosensors for Point-of-Care Diagnostics Product Portfolio Table 87. Sysmex Corporation Recent Development Table 88. Siemens Company Information Table 89. Siemens Business Overview Table 90. Siemens Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Siemens Biosensors for Point-of-Care Diagnostics Product Portfolio Table 92. Siemens Recent Development Table 93. Pharmaco-Kinesis Corporation (PKC) Company Information Table 94. Pharmaco-Kinesis Corporation (PKC) Business Overview Table 95. Pharmaco-Kinesis Corporation (PKC) Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Pharmaco-Kinesis Corporation (PKC) Biosensors for Point-of-Care Diagnostics Product Portfolio Table 97. Pharmaco-Kinesis Corporation (PKC) Recent Development Table 98. Nova Biomedical Company Information Table 99. Nova Biomedical Business Overview Table 100. Nova Biomedical Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Nova Biomedical Biosensors for Point-of-Care Diagnostics Product Portfolio Table 102. Nova Biomedical Recent Development Table 103. LifeSensors Company Information Table 104. LifeSensors Business Overview Table 105. LifeSensors Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. LifeSensors Biosensors for Point-of-Care Diagnostics Product Portfolio Table 107. LifeSensors Recent Development Table 108. LifeScan Company Information Table 109. LifeScan Business Overview Table 110. LifeScan Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. LifeScan Biosensors for Point-of-Care Diagnostics Product Portfolio Table 112. LifeScan Recent Development Table 113. F. Hoffman-La Roche Company Information Table 114. F. Hoffman-La Roche Business Overview Table 115. F. Hoffman-La Roche Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. F. Hoffman-La Roche Biosensors for Point-of-Care Diagnostics Product Portfolio Table 117. F. Hoffman-La Roche Recent Development Table 118. Ercon Company Information Table 119. Ercon Business Overview Table 120. Ercon Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Ercon Biosensors for Point-of-Care Diagnostics Product Portfolio Table 122. Ercon Recent Development Table 123. Biosensors International Company Information Table 124. Biosensors International Business Overview Table 125. Biosensors International Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Biosensors International Biosensors for Point-of-Care Diagnostics Product Portfolio Table 127. Biosensors International Recent Development Table 128. Bio-Rad Laboratories Company Information Table 129. Bio-Rad Laboratories Business Overview Table 130. Bio-Rad Laboratories Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Bio-Rad Laboratories Biosensors for Point-of-Care Diagnostics Product Portfolio Table 132. Bio-Rad Laboratories Recent Development Table 133. Biacore Company Information Table 134. Biacore Business Overview Table 135. Biacore Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Biacore Biosensors for Point-of-Care Diagnostics Product Portfolio Table 137. Biacore Recent Development Table 138. Bayer Healthcare Company Information Table 139. Bayer Healthcare Business Overview Table 140. Bayer Healthcare Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Bayer Healthcare Biosensors for Point-of-Care Diagnostics Product Portfolio Table 142. Bayer Healthcare Recent Development Table 143. Acon Laboratories Company Information Table 144. Acon Laboratories Business Overview Table 145. Acon Laboratories Biosensors for Point-of-Care Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Acon Laboratories Biosensors for Point-of-Care Diagnostics Product Portfolio Table 147. Acon Laboratories Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Biosensors for Point-of-Care Diagnostics Distributors List Table 151. Biosensors for Point-of-Care Diagnostics Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Biosensors for Point-of-Care Diagnostics Product Image Figure 2. Global Biosensors for Point-of-Care Diagnostics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biosensors for Point-of-Care Diagnostics Sales (2021-2032) & (k units) Figure 5. Global Biosensors for Point-of-Care Diagnostics Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Biosensors for Point-of-Care Diagnostics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Electrochemical Biosensors Image Figure 10. Optical Biosensors Image Figure 11. Accelerometer Biosensors Image Figure 12. Thermal Biosensors Image Figure 13. Piezoelectric Biosensors Image Figure 14. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Type (2021-2032) Figure 17. Global Biosensors for Point-of-Care Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biosensors for Point-of-Care Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Type (2021-2032) Figure 20. Clinic Image Figure 21. Hospital Image Figure 22. Home Care Image Figure 23. Others Image Figure 24. Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Application (2021-2032) Figure 27. Global Biosensors for Point-of-Care Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Biosensors for Point-of-Care Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Application (2021-2032) Figure 30. Global Biosensors for Point-of-Care Diagnostics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Biosensors for Point-of-Care Diagnostics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Biosensors for Point-of-Care Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 35. North America Biosensors for Point-of-Care Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Biosensors for Point-of-Care Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Biosensors for Point-of-Care Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 41. South America Biosensors for Point-of-Care Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Biosensors for Point-of-Care Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Biosensors for Point-of-Care Diagnostics Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Biosensors for Point-of-Care Diagnostics Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Electrochemical Biosensors
  • Optical Biosensors
  • Accelerometer Biosensors
  • Thermal Biosensors
  • Piezoelectric Biosensors
Applications
  • Clinic
  • Hospital
  • Home Care
  • Others
Companies covered
  • Abbott
  • Medtronic
  • Universal Biosensors
  • Sysmex Corporation
  • Siemens
  • Pharmaco-Kinesis Corporation (PKC)
  • Nova Biomedical
  • LifeSensors
  • LifeScan
  • F. Hoffman-La Roche
  • Ercon
  • Biosensors International
  • Bio-Rad Laboratories
  • Biacore
  • Bayer Healthcare
  • Acon Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032)
  4. 1.2.2 Global Biosensors for Point-of-Care Diagnostics Sales Volume (2021-2032)
  5. 1.2.3 Global Biosensors for Point-of-Care Diagnostics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biosensors for Point-of-Care Diagnostics Market Dynamics
  1. 2.1 Biosensors for Point-of-Care Diagnostics Industry Trends
  2. 2.2 Biosensors for Point-of-Care Diagnostics Industry Drivers
  3. 2.3 Biosensors for Point-of-Care Diagnostics Industry Opportunities and Challenges
  4. 2.4 Biosensors for Point-of-Care Diagnostics Industry Restraints
3 Biosensors for Point-of-Care Diagnostics Market by Company
  1. 3.1 Global Biosensors for Point-of-Care Diagnostics Company Revenue Ranking in 2025
  2. 3.2 Global Biosensors for Point-of-Care Diagnostics Revenue by Company (2021-2026)
  3. 3.3 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Company (2021-2026)
  4. 3.4 Global Biosensors for Point-of-Care Diagnostics Average Price by Company (2021-2026)
  5. 3.5 Global Biosensors for Point-of-Care Diagnostics Company Ranking (2024-2026)
  6. 3.6 Global Biosensors for Point-of-Care Diagnostics Company Manufacturing Base and Headquarters
  7. 3.7 Global Biosensors for Point-of-Care Diagnostics Company Product Type and Application
  8. 3.8 Global Biosensors for Point-of-Care Diagnostics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biosensors for Point-of-Care Diagnostics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biosensors for Point-of-Care Diagnostics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biosensors for Point-of-Care Diagnostics Market by Type
  1. 4.1 Biosensors for Point-of-Care Diagnostics Type Introduction
  2. 4.1.1 Electrochemical Biosensors
  3. 4.1.2 Optical Biosensors
  4. 4.1.3 Accelerometer Biosensors
  5. 4.1.4 Thermal Biosensors
  6. 4.1.5 Piezoelectric Biosensors
  7. 4.2 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type
  8. 4.2.1 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Biosensors for Point-of-Care Diagnostics Sales Value by Type
  12. 4.3.1 Global Biosensors for Point-of-Care Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Biosensors for Point-of-Care Diagnostics Sales Value by Type (2021-2032)
  14. 4.3.3 Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Type (2021-2032)
5 Biosensors for Point-of-Care Diagnostics Market by Application
  1. 5.1 Biosensors for Point-of-Care Diagnostics Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Home Care
  5. 5.1.4 Others
  6. 5.2 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application
  7. 5.2.1 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Biosensors for Point-of-Care Diagnostics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Biosensors for Point-of-Care Diagnostics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Biosensors for Point-of-Care Diagnostics Sales Value by Application
  11. 5.3.1 Global Biosensors for Point-of-Care Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Biosensors for Point-of-Care Diagnostics Sales Value by Application (2021-2032)
  13. 5.3.3 Global Biosensors for Point-of-Care Diagnostics Sales Value Share by Application (2021-2032)
6 Biosensors for Point-of-Care Diagnostics Regional Sales and Value Analysis
  1. 6.1 Global Biosensors for Point-of-Care Diagnostics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biosensors for Point-of-Care Diagnostics Sales by Region (2021-2032)
  3. 6.2.1 Global Biosensors for Point-of-Care Diagnostics Sales by Region: 2021-2026
  4. 6.2.2 Global Biosensors for Point-of-Care Diagnostics Sales by Region (2027-2032)
  5. 6.3 Global Biosensors for Point-of-Care Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biosensors for Point-of-Care Diagnostics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biosensors for Point-of-Care Diagnostics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biosensors for Point-of-Care Diagnostics Sales Value by Region (2027-2032)
  9. 6.5 Global Biosensors for Point-of-Care Diagnostics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032)
  12. 6.6.2 North America Biosensors for Point-of-Care Diagnostics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032)
  15. 6.7.2 Europe Biosensors for Point-of-Care Diagnostics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biosensors for Point-of-Care Diagnostics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032)
  21. 6.9.2 South America Biosensors for Point-of-Care Diagnostics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biosensors for Point-of-Care Diagnostics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biosensors for Point-of-Care Diagnostics Sales Value Share by Country, 2025 VS 2032
7 Biosensors for Point-of-Care Diagnostics Country-level Sales and Value Analysis
  1. 7.1 Global Biosensors for Point-of-Care Diagnostics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biosensors for Point-of-Care Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2032)
  4. 7.3.1 Global Biosensors for Point-of-Care Diagnostics Sales by Country (2021-2026)
  5. 7.3.2 Global Biosensors for Point-of-Care Diagnostics Sales by Country (2027-2032)
  6. 7.4 Global Biosensors for Point-of-Care Diagnostics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biosensors for Point-of-Care Diagnostics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biosensors for Point-of-Care Diagnostics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biosensors for Point-of-Care Diagnostics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biosensors for Point-of-Care Diagnostics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biosensors for Point-of-Care Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Biosensors for Point-of-Care Diagnostics Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Biosensors for Point-of-Care Diagnostics Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Universal Biosensors
  14. 8.3.1 Universal Biosensors Company Information
  15. 8.3.2 Universal Biosensors Business Overview
  16. 8.3.3 Universal Biosensors Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Universal Biosensors Biosensors for Point-of-Care Diagnostics Product Portfolio
  18. 8.3.5 Universal Biosensors Recent Developments
  19. 8.4 Sysmex Corporation
  20. 8.4.1 Sysmex Corporation Company Information
  21. 8.4.2 Sysmex Corporation Business Overview
  22. 8.4.3 Sysmex Corporation Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sysmex Corporation Biosensors for Point-of-Care Diagnostics Product Portfolio
  24. 8.4.5 Sysmex Corporation Recent Developments
  25. 8.5 Siemens
  26. 8.5.1 Siemens Company Information
  27. 8.5.2 Siemens Business Overview
  28. 8.5.3 Siemens Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Biosensors for Point-of-Care Diagnostics Product Portfolio
  30. 8.5.5 Siemens Recent Developments
  31. 8.6 Pharmaco-Kinesis Corporation (PKC)
  32. 8.6.1 Pharmaco-Kinesis Corporation (PKC) Company Information
  33. 8.6.2 Pharmaco-Kinesis Corporation (PKC) Business Overview
  34. 8.6.3 Pharmaco-Kinesis Corporation (PKC) Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pharmaco-Kinesis Corporation (PKC) Biosensors for Point-of-Care Diagnostics Product Portfolio
  36. 8.6.5 Pharmaco-Kinesis Corporation (PKC) Recent Developments
  37. 8.7 Nova Biomedical
  38. 8.7.1 Nova Biomedical Company Information
  39. 8.7.2 Nova Biomedical Business Overview
  40. 8.7.3 Nova Biomedical Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nova Biomedical Biosensors for Point-of-Care Diagnostics Product Portfolio
  42. 8.7.5 Nova Biomedical Recent Developments
  43. 8.8 LifeSensors
  44. 8.8.1 LifeSensors Company Information
  45. 8.8.2 LifeSensors Business Overview
  46. 8.8.3 LifeSensors Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LifeSensors Biosensors for Point-of-Care Diagnostics Product Portfolio
  48. 8.8.5 LifeSensors Recent Developments
  49. 8.9 LifeScan
  50. 8.9.1 LifeScan Company Information
  51. 8.9.2 LifeScan Business Overview
  52. 8.9.3 LifeScan Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 LifeScan Biosensors for Point-of-Care Diagnostics Product Portfolio
  54. 8.9.5 LifeScan Recent Developments
  55. 8.10 F. Hoffman-La Roche
  56. 8.10.1 F. Hoffman-La Roche Company Information
  57. 8.10.2 F. Hoffman-La Roche Business Overview
  58. 8.10.3 F. Hoffman-La Roche Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 F. Hoffman-La Roche Biosensors for Point-of-Care Diagnostics Product Portfolio
  60. 8.10.5 F. Hoffman-La Roche Recent Developments
  61. 8.11 Ercon
  62. 8.11.1 Ercon Company Information
  63. 8.11.2 Ercon Business Overview
  64. 8.11.3 Ercon Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ercon Biosensors for Point-of-Care Diagnostics Product Portfolio
  66. 8.11.5 Ercon Recent Developments
  67. 8.12 Biosensors International
  68. 8.12.1 Biosensors International Company Information
  69. 8.12.2 Biosensors International Business Overview
  70. 8.12.3 Biosensors International Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Biosensors International Biosensors for Point-of-Care Diagnostics Product Portfolio
  72. 8.12.5 Biosensors International Recent Developments
  73. 8.13 Bio-Rad Laboratories
  74. 8.13.1 Bio-Rad Laboratories Company Information
  75. 8.13.2 Bio-Rad Laboratories Business Overview
  76. 8.13.3 Bio-Rad Laboratories Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bio-Rad Laboratories Biosensors for Point-of-Care Diagnostics Product Portfolio
  78. 8.13.5 Bio-Rad Laboratories Recent Developments
  79. 8.14 Biacore
  80. 8.14.1 Biacore Company Information
  81. 8.14.2 Biacore Business Overview
  82. 8.14.3 Biacore Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biacore Biosensors for Point-of-Care Diagnostics Product Portfolio
  84. 8.14.5 Biacore Recent Developments
  85. 8.15 Bayer Healthcare
  86. 8.15.1 Bayer Healthcare Company Information
  87. 8.15.2 Bayer Healthcare Business Overview
  88. 8.15.3 Bayer Healthcare Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Healthcare Biosensors for Point-of-Care Diagnostics Product Portfolio
  90. 8.15.5 Bayer Healthcare Recent Developments
  91. 8.16 Acon Laboratories
  92. 8.16.1 Acon Laboratories Company Information
  93. 8.16.2 Acon Laboratories Business Overview
  94. 8.16.3 Acon Laboratories Biosensors for Point-of-Care Diagnostics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Acon Laboratories Biosensors for Point-of-Care Diagnostics Product Portfolio
  96. 8.16.5 Acon Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biosensors for Point-of-Care Diagnostics Value Chain Analysis
  2. 9.1.1 Biosensors for Point-of-Care Diagnostics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biosensors for Point-of-Care Diagnostics Sales Mode & Process
  6. 9.2 Biosensors for Point-of-Care Diagnostics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biosensors for Point-of-Care Diagnostics Distributors
  9. 9.2.3 Biosensors for Point-of-Care Diagnostics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst